Company news

Arbutus Biopharma Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Arbutus Reports Fourth Quarter and Year End 2019 Financial Results, Confirms 2020 Corporate Objectives and Provides Pipeline Update

March 4, 2020

Arbutus to Report Fourth Quarter and Year-End 2019 Financial Results

February 26, 2020

Arbutus Announces Decision to Discontinue AB-452 and to Pursue Development of a Next Generation HBV Specific Oral RNA-Destabilizer

February 9, 2020

Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 5, 2019

Arbutus to Report Third Quarter 2019 Financial Results

October 29, 2019

Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B

October 2, 2019

← Newer news releases

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 54 decks. Every deck is listed under its year.